| Testing
the vaccines
Cape
Town Clinical Trials Consortium
Contact:
Dr Linda-Gail Bekker
Tel: +27 21 650-6962
E-mail: linda-gail.bekker@hiv-research.org.za
The Cape Town HIV Vaccine Clinical Trials
Consortium was established in October 2002 and
comprises a multifaceted group of researchers
who conduct multidisciplinary research in HIV
and are part of SAAVI. The Consortium offers
a fully functional and sustainable HIV Vaccine
Clinical Trials Unit in Cape Town able to conduct
phase I and II human trials of HIV/AIDS candidate
preventative vaccines under good clinical and
ethical practice for all age and ethnic groups
in South Africa. It is currently actively engaged
in socio-behavioural, educational and infrastructural
development of phase III sites in the communities
of Masiphumelele and Nyanga/Mitchell’s
Plain, Cape Town.
To
date, the consortium has focused on site, protocol
and research tool development; the commencement
of two retention studies; enhancing communication between community
structures and researchers; and, developing culturally
attuned education programmes.
View a list of publications and papers for the Cape Town Clinical Trials Consortium.
|
|
Partners
Making the vaccines
 The University of Cape Town (UCT)
Testing the vaccines
HIV Vaccine Research Unit, MRC, Durban
HIV Vaccine Division of the Perinatal HIV Research Unit (PHRU)
Aurum Health
Cape Town Clinical Trials Consortium
Immunology assessment
The National Institute for Communicable Diseases (NICD)
Ethical issues
HIV/AIDS Vaccine Ethics Group (HAVEG), University of KwaZulu-Natal
Community involvement
Masikhulisane SAAVI Community Involvement Group
Behavioural science
Socio-behavioural research group
Actuarial assessments
Actuarial Group
Data and bioinformatics
Data Management (MRC) |
